{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:05:33Z","timestamp":1790838333444,"version":"4.1.0"},"reference-count":19,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2014,10]]},"abstract":"<jats:p>Molluscum contagiosum is a common reason for consultation in primary care. The condition is normally benign and self-limiting1 and the standard advice is to wait for the lesions to resolve spontaneously.2 Recently, potassium hydroxide 5% (MolluDab\u2014Alliance Pharmaceuticals Limited) has been marketed in the UK for the treatment of the condition.3 It is sold as a medical device rather than a licensed medicinal product. Here we consider the evidence for potassium hydroxide 5% in the management of molluscum contagiosum.<\/jats:p>","DOI":"10.1136\/dtb.2014.10.0285","type":"journal-article","created":{"date-parts":[[2014,10,8]],"date-time":"2014-10-08T04:12:35Z","timestamp":1412741555000},"page":"118-120","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Potassium hydroxide 5% for the treatment of molluscum contagiosum"],"prefix":"10.1136","volume":"52","member":"239","published-online":{"date-parts":[[2014,10,8]]},"reference":[{"key":"2025082702563185000_52.10.118.1","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1473-3099(13)70109-9","article-title":"Molluscum contagiosum virus infection","volume":"13","author":"Chen","year":"2013","journal-title":"Lancet"},{"key":"2025082702563185000_52.10.118.2","unstructured":"National Institute for Health and Care Excellence, 2012. Clinical knowledge summaries: Molluscum contagiosum [online]. Available: http:\/\/cks.nice.org.uk\/molluscum-contagiosum [Accessed 17 September 2014]."},{"key":"2025082702563185000_52.10.118.3","unstructured":"Alliance Pharmaceuticals Limited, 2013. MolluDab [online]. Available: http:\/\/www.molludab.co.uk\/molluscum-contagiosum [Accessed 17 September 2014]."},{"key":"2025082702563185000_52.10.118.4","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmt075"},{"key":"2025082702563185000_52.10.118.5","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp14X680941"},{"key":"2025082702563185000_52.10.118.6","first-page":"CD004767","article-title":"Interventions for cutaneous molluscum contagiosum","volume":"4","author":"van der Wouden","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"2025082702563185000_52.10.118.7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1524-4725.2011.02293.x","article-title":"Pulsed dye laser and pulsed dye laser-mediated photodynamic therapy in the treatment of dermatologic disorders","volume":"38","author":"Liu","year":"2012","journal-title":"Dermatol Surg"},{"key":"2025082702563185000_52.10.118.8","unstructured":"The Pharmaceutical Press, 2014. Martindale: the complete drug reference [online]. Available: https:\/\/www.medicinescomplete.com\/mc\/martindale\/current\/index.htm [Accessed 17 September 2014]."},{"key":"2025082702563185000_52.10.118.9","doi-asserted-by":"publisher","DOI":"10.1136\/dtb.2020.03.0023"},{"key":"2025082702563185000_52.10.118.10","unstructured":"European Commission, 2009. Medical devices guidance document MEDDEV 2.1\/3 rev 3 [online]. Available: http:\/\/ec.europa.eu\/health\/medical-devices\/files\/meddev\/2_1_3_rev_3-12_2009_en.pdf [Accessed 17 September 2014]."},{"key":"2025082702563185000_52.10.118.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2006.00235.x"},{"key":"2025082702563185000_52.10.118.12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/15569527.2013.796479","article-title":"Comparative study of 5% and 2.5% potassium hydroxide solution for molluscum contagiosum in children","volume":"33","author":"U\u00e7mak","year":"2014","journal-title":"Cutan Ocul Toxicol"},{"key":"2025082702563185000_52.10.118.13","first-page":"291","article-title":"Comparative study of 5% potassium hydroxide solution versus 0.05% tretinoin cream for molluscum contagiosum in children","volume":"36","author":"Rajouria","year":"2011","journal-title":"Kathmandu Univ Med"},{"key":"2025082702563185000_52.10.118.14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/09546634.2011.649690","article-title":"An open, comparative study of 10% potassium hydroxide solution versus salicylic and lactic acid combination in the treatment of molluscum contagiosum in children","volume":"24","author":"K\u00f6se","year":"2013","journal-title":"J Dermatolog Treat"},{"key":"2025082702563185000_52.10.118.15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/09546634.2013.832135","article-title":"Comparison of 10% potassium hydroxide solution versus cryotherapy in the treatment of molluscum contagiosum: an open randomized clinical trial","volume":"25","author":"Handjani","year":"2014","journal-title":"J Dermatolog Treat"},{"key":"2025082702563185000_52.10.118.16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5021\/ad.2010.22.2.156","article-title":"An open, randomized, comparative clinical and histological study of imiquimod 5% cream versus 10% potassium hydroxide solution in the treatment of molluscum contagiosum","volume":"22","author":"Seo","year":"2010","journal-title":"Ann Dermatol"},{"key":"2025082702563185000_52.10.118.17","unstructured":"NHS Business Services Authority, 2014. National Health Service England and Wales Electronic Drug Tariff [online]. Available: http:\/\/www.ppa.org.uk\/edt\/September_2014\/mindex.htm [Accessed 17 September 2014]."},{"key":"2025082702563185000_52.10.118.18","unstructured":"Personal communication. Don Page, National Services NHS Scotland. 22 August 2014."},{"key":"2025082702563185000_52.10.118.19","unstructured":"Department for Business, Innovation & Skills, 2012. CE marking: guidance [online]. Available: https:\/\/www.gov.uk\/ce-marking [Accessed 17 September 2014]."}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2014.10.0285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T09:57:01Z","timestamp":1756288621000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2014.10.0285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":19,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,8]]},"published-print":{"date-parts":[[2014,10]]}},"alternative-id":["10.1136\/dtb.2014.10.0285"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2014.10.0285","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"value":"0012-6543","type":"print"},{"value":"1755-5248","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}